Form 4: 10x Genomics CEO Serge Saxonov Reports Gift of Shares in Latest SEC Filing

10x Genomics, Inc. CEO and Director Serge Saxonov has filed a Form 4, disclosing the gifting of 3,000 shares of Class A Common Stock on May 29, 2025, reducing his direct beneficial ownership.

Summary

• Serge Saxonov, Chief Executive Officer, Director, and 10% Owner of 10x Genomics, Inc. (TXG), filed a Form 4.
• The filing reports a disposition of 3,000 shares of Class A Common Stock on May 29, 2025, via a gift (Transaction Code 'G').
• The shares were disposed of at a price of $0 per share, consistent with a gift.
• Following this transaction, Mr. Saxonov directly beneficially owns 1,080,625 shares of Class A Common Stock.
• Additionally, Mr. Saxonov indirectly beneficially owns 27 shares through the Andromeda Trust, 870 shares through the Sirius Trust, 213,250 shares through the Y/S Descendants' Trust, and 22,570 shares through the Y/S Pot Trust, for which he serves as trustee.

Sentiment

Score: 5

Explanation: The sentiment is neutral. A gift of shares is a personal financial decision and does not typically reflect on the company's operational performance or future prospects. It is not a sale for cash, which might be viewed more negatively.

Negatives

• The transaction represents a reduction in the direct beneficial ownership of the CEO, though it is a gift rather than a sale for cash.

Risks

• While a gift, the reduction in direct insider ownership could be perceived as a minor, indirect risk regarding management's direct alignment with shareholder interests, though the overall beneficial ownership remains substantial.

Future Outlook

This Form 4 filing is a disclosure of an insider transaction and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is a standard insider transaction report and does not provide insights into broader industry trends or competitive dynamics within the genomics or life sciences sector. It reflects a personal financial decision by the CEO.

Related Party Transactions

• Serge Saxonov indirectly holds shares through various trusts (Andromeda Trust, Sirius Trust, Y/S Descendants' Trust, Y/S Pot Trust) for which he serves as trustee, indicating beneficial ownership through related entities.

Stakeholder Impact

• Shareholders: Minimal direct impact, as the transaction is a gift and not a sale for cash, and the number of shares gifted is a small fraction of the CEO's total beneficial ownership.
• Employees, Customers, Suppliers, Creditors: No direct impact from this insider transaction.

Key Dates

Keywords

10x Genomics, TXG, Serge Saxonov, Form 4, Insider Transaction, Beneficial Ownership, Stock Gift, CEO, Director